Skip to content

Q&A: CARBOGEN AMCIS dedicates new site to sterile liquid drug manufacturing

As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products.

Q&A: CARBOGEN AMCIS dedicates new site to sterile liquid drug manufacturing
Published: | 4 min read

As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in Saint-Beauzire, France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products.

CARBOGEN AMCIS SAS © Gilles Framinet

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information